Literature DB >> 31375274

Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.

Zhen Feng1, Xiaomeng Shi1, Qianshi Zhang1, Xinsheng Zhang1, Xiaomeng Li2, Zihao Chen1, Dunbo Liu1, Bisheng Sun1, Yunfei Zuo3, Shuangyi Ren4.   

Abstract

PURPOSE: Compare and analyze the clinicopathological features and prognosis of 1315 patients with colorectal cancer located at different anatomical subsites.
METHODS: A retrospective study was conducted to analyze the clinicopathological features and prognosis from 1315 patients with colorectal cancer who underwent surgery in the department of gastrointestinal surgery at the Second Affiliated Hospital of Dalian Medical University from January 2013 to January 2019. Among them, 287 patients were divided into the right-sided colon cancer (RCC) group; 329 patients were included into the left-sided colon cancer (LCC) group and the remaining 699 patients were assigned to the rectal cancer (RC) group. Clinicopathological features such as gender, age, pathological differentiation, neurovascular invasion, TNM stage, related tumor markers, maximum tumor diameter (MTD), median survival time and overall survival rate were extracted and analyzed.
RESULTS: Patients in the RCC group had the oldest age of onset, highest positive rate of serum CA199 and greatest number of poorly differentiated adenocarcinomas among the three groups and significant statistical differences were found. The RC group had the highest positive rate of vascular invasion (42.9%) and the greatest number of patients in stage I and IV (19% and 3.9%, respectively). Besides, the number of patients with stage T1-T2 adenocarcinoma in RC group was also the highest among the three groups. There were no significant differences in gender, perineural invasion as well as serum levels of CEA, CA724 and CA242. The median survival time of RCC, LCC and RC were 72, 70 and 73 months, respectively, with significant inter-group differences (P = 0.049).
CONCLUSION: The age of onset of right-sided colon cancer is the oldest on average and poorly differentiated tumors accounted for the highest proportion. Besides, average maximum tumor diameter is the largest in right-sided colon cancer. In terms of median survival time, LCC is worse than RCC and RC. Colorectal cancer at different anatomical subsites has different epidemiological, clinicopathological features and prognosis. Fully understanding the clinicopathological features of colorectal cancer at different anatomical subsites is of certain guiding significance for the clinical diagnosis and treatment of colorectal cancer, and is conducive to individualized treatment and accurate treatment.
Copyright © 2019. Published by Elsevier GmbH.

Entities:  

Keywords:  Clinicopathological features; Colorectal cancer; Left-sided colon cancer; Right-sided colon cancer

Mesh:

Year:  2019        PMID: 31375274     DOI: 10.1016/j.prp.2019.152560

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

1.  A nine-gene signature to improve prognosis prediction of colon carcinoma.

Authors:  Jinlai Zhao; Yigang Wang; Jianchao Gao; Yang Wang; Xuan Zhong; Xiaotang Wu; Hua Li
Journal:  Cell Cycle       Date:  2021-05-14       Impact factor: 4.534

2.  Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal Adenocarcinoma.

Authors:  Yanfen Cui; Baoai Han; He Zhang; Hui Liu; Fei Zhang; Ruifang Niu
Journal:  Onco Targets Ther       Date:  2021-03-31       Impact factor: 4.147

3.  Can transrectal ultrasonography distinguish anorectal malignant melanoma from low rectal adenocarcinoma? A retrospective paired study for ten years.

Authors:  Jingwen Yan; Jigang Jing; Shuang Wu; Lacong Geiru; Hua Zhuang
Journal:  BMC Gastroenterol       Date:  2022-04-05       Impact factor: 3.067

4.  Predictive Values of the Selected Inflammatory Indexes in Colon Cancer.

Authors:  Li Huang; Zuojian Hu; Ruixian Luo; Hailan Li; Ziji Yang; Xue Qin; Zhuning Mo
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

5.  Decreased expression of farnesoid X receptor may indicate poor prognosis in patients with colorectal cancer.

Authors:  Danying Zhang; Shuqiang Weng; Can Cui; Ling Dong; Xizhong Shen
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.